Meyka Pro banner

United States Forecast Overvalued Stocks – November 2026

Explore stocks in United States trading above analyst forecast fair value for November 2026, including Berkshire Hathaway Inc. (BRK-A), Mettler-Toledo International Inc. (MTD), W.W. Grainger, Inc. (GWW). These equities on the NYSE & NASDAQ are currently priced above consensus analyst targets, signaling potential overvaluation risk and caution for investors.

Signal Criteria
Price>Yearly Forecast
Yearly Forecast
SymbolPriceChangeVolumeMarket CapSector / IndustryYearly ForecastGRADE
BRK-A
Berkshire Hathaway Inc.
$854,452.41
-0.53%
-4,547.59
1611.2TFinancial Services831,765.09
B+Grade
MTD
Mettler-Toledo International Inc.
$1,666.88
-2.27%
-38.78
143.7K33.2BHealthcare1,564.61
B+Grade
GWW
W.W. Grainger, Inc.
$1,357.35
-4.67%
-66.53
478.3K63.6BIndustrials1,325.38
Z
Grade
LLY
Eli Lilly and Company
$1,347.11
-0.30%
-4.01
3.5M1.3THealthcare1,210.72
Z
Grade
COST
Costco Wholesale Corporation
$1,102.15
+0.76%
+8.32
4.1M489.3BConsumer Defensive1,088.29
Z
Grade
MCK
McKesson Corporation
$1,069.43
+0.68%
+7.27
798.7K123.5BHealthcare923.95
Z
Grade
ARGX
argenx SE
$925.70
-1.73%
-16.34
235.3K58.2BHealthcare916.76
Z
Grade
REGN
Regeneron Pharmaceuticals, Inc.
$920.69
-0.19%
-1.71
855K95.3BHealthcare799.56
Z
Grade
BWET
Breakwave Tanker Shipping ETF
$745.77
+0.74%
+5.48
47.9K81.5MFinancial Services220.62
Z
Grade
IDXX
IDEXX Laboratories, Inc.
$676.21
-1.95%
-13.44
614.3K53.3BHealthcare643.27
Z
Grade
TMO
Thermo Fisher Scientific Inc.
$669.54
-2.79%
-19.21
2.4M248.5BHealthcare552.15
Z
Grade
CVCO
Cavco Industries, Inc.
$640.53
-1.46%
-9.47
104.6K4.9BConsumer Cyclical640.32
Z
Grade
MA
Mastercard Incorporated
$625.59
-0.15%
-0.91
3.7M545.3BFinancial Services618.89
Z
Grade
ULTA
Ulta Beauty, Inc.
$615.74
-2.16%
-13.60
533.5K26.3BConsumer Cyclical600.62
Z
Grade
MEDP
Medpace Holdings, Inc.
$610.54
-3.70%
-23.44
236.6K17.1BHealthcare586.53
Z
Grade
MSCI
MSCI Inc.
$610.48
-2.22%
-13.85
802.9K43.7BFinancial Services597.22
Z
Grade
DE
Deere & Company
$609.25
-2.50%
-15.64
2.2M164.3BIndustrials585.74
Z
Grade
MU
Micron Technology, Inc.
$594.51
-13.89%
-95.93
58.2M673BTechnology485.47
Z
Grade
BRK-B
Berkshire Hathaway Inc.
$569.88
-0.38%
-2.16
6.6M800.5BFinancial Services554.55
Z
Grade
LMT
Lockheed Martin Corporation
$565.50
-1.11%
-6.35
1.3M130.6BIndustrials543.73
Z
Grade
UTHR
United Therapeutics Corporation
$554.73
-0.78%
-4.37
355.1K23.6BHealthcare533.89
Z
Grade
CHE
Chemed Corporation
$548.59
-0.50%
-2.74
135K7.1BHealthcare496.70
Z
Grade
MSI
Motorola Solutions, Inc.
$520.21
-0.33%
-1.71
1.3M86BTechnology386.05
Z
Grade
VRTX
Vertex Pharmaceuticals Incorporated
$515.02
-1.08%
-5.64
1.7M130.6BHealthcare508.79
Z
Grade
HCA
HCA Healthcare, Inc.
$475.57
+3.31%
+15.24
1.6M99.3BHealthcare474.41
Z
Grade
LITE
Lumentum Holdings Inc.
$460.54
-13.94%
-74.61
5.7M41.8BTechnology415.22
Z
Grade
ATRI
Atrion Corporation
$459.92
+0.06%
+0.26
29.5K809.4MHealthcare300.18
Z
Grade
STX
Seagate Technology Holdings plc
$457.01
-12.35%
-64.38
5.9M105.2BTechnology407.37
Z
Grade
WAT
Waters Corporation
$440.45
-3.51%
-16.03
1.4M43.3BHealthcare399.94
Z
Grade
AMGN
Amgen Inc.
$435.64
-0.15%
-0.66
4.9M235.8BHealthcare369.54
Z
Grade
1

Understanding Forecast Overvalued Stocks

United States Forecast Overvalued Stocks – [November 2026]

Explore stocks in United States currently trading above their estimated fair value based on analyst forecasts, filtered by Market Cap: All, Grade: All, Volume: All, Price: All.

Within this filtered view across NYSE & NASDAQ, the equities showing the highest premium to consensus price targets include Berkshire Hathaway Inc. (BRK-A), Mettler-Toledo International Inc. (MTD), and W.W. Grainger, Inc. (GWW). These stocks are trading above their forecasted fair values, suggesting potential overvaluation risk within the All segment of the United States equity market.

Understanding Forecast Overvalued Stocks

The Forecast Overvalued Stocks screen identifies equities listed on NYSE & NASDAQ whose current market price exceeds analyst consensus fair value estimates, filtered by All market cap, All rating, All trading activity, and All price range.

Rankings are dynamically calculated using real-time data, including:

  • Current Price: $854,452.41, $1,666.88, $1,357.35
  • Trading Volume: 161, 143.7K, 478.3K
  • Market Capitalization: 1.2T, 33.2B, 63.6B
  • Sector / Industry: Financial Services, Healthcare, Industrials

Because this dataset adapts to All and All conditions, investors can pinpoint overvalued stocks within specific segments of the United States market, rather than relying on broad, unfiltered comparisons.

Why Track Forecast Overvalued Stocks in United States?

Market Insights
  • Monitoring overvalued stocks within United States under Market Cap: All and Grade: All provides insight into valuation excesses and market inefficiencies.
  • Using these filters, you can identify equities on NYSE & NASDAQ trading at a premium to analyst price targets within the All range.
  • Detect sectors in United States where valuation expansion may have outpaced fundamentals.
  • Track stocks with All liquidity profiles that show signs of stretched pricing.
  • Compare valuation risk across industries within the All category.
Trading & Risk Management Opportunities
  • The Forecast Overvalued Stocks list filtered by All and All is particularly useful for identifying risk management signals and potential downside setups.
  • With this dataset, traders and investors can spot stocks trading significantly above analyst fair value benchmarks within the All range.
  • Identify equities in United States showing overvaluation alongside weakening momentum signals.
  • Evaluate positions where price exceeds fundamental justification within the All band.
  • Combine overvaluation signals with earnings risk, analyst downgrades, or technical indicators for better decision-making.
Filter-Based Market View
  • All insights on this page are dynamically shaped by your selected filters: Market Cap: All, Grade: All, Volume: All, Price: All, Country: United States, Exchanges: NYSE & NASDAQ.
  • As these filters change, the stocks, valuation metrics, and analytical insights automatically update, ensuring the content always reflects the specific segment of the United States equity market you are analyzing.

Related Resources

Frequently Asked Questions

Forecast overvalued stocks are equities whose current market price exceeds the consensus analyst forecast fair value. Currently, BRK-A is among the overvalued stocks with a price of $854,452.41, a -0.53% change, and trading volume of 161.
MEYKA compares current market prices against consensus analyst price targets, using real-time data including current price ($854,452.41), volume (161), and market cap (1.2T) to rank stocks by their premium above analyst fair value on the NYSE & NASDAQ.
Not necessarily. Stocks can trade above analyst targets for extended periods, especially during strong bull markets or when fundamentals improve faster than analysts revise targets. However, elevated premiums to fair value do increase downside risk and warrant closer monitoring.
MEYKA updates the forecast overvalued stocks list in real time, continuously tracking changes in price ($854,452.41), percentage change (-0.53%), volume (161), and market cap (1.2T) relative to analyst targets.
Yes. Combining forecast overvalued stocks with bearish technical signals, weakening earnings momentum, or analyst downgrade activity can help identify higher-probability setups for risk management or potential short-sale opportunities.